Mesenchymal stem cells- an excellent therapeutic agent for cancer

dc.contributor.authorTomyTomcy, Anjilikal
dc.contributor.authorSindhu, Edakkadath Raghavan
dc.date.accessioned2024-01-21T10:54:14Z
dc.date.accessioned2024-08-14T07:40:58Z
dc.date.available2024-01-21T10:54:14Z
dc.date.available2024-08-14T07:40:58Z
dc.date.issued2023-05-16T00:00:00
dc.description.abstractDespite rapid advancement in research of diagnostics and therapeutics, cancer is the most dangerous disease-causing millions of deaths worldwide. Many of the conventional anticancer therapies can even lead to developing resistance to therapy and recurrence of cancer. To find a new, alternative treatment strategy for a variety of ailments scientists and researchers have turned their attention to cell therapies and regenerative medicine. Stem cells are now being researched for their extensive potential application in therapy for several incurable illnesses including cancer. One of the most often employed cell types for regenerative medicine is mesenchymal stem cells. Mesenchymal stem cells (MSCs) are considered a promising source of stem cells in personalized cell-based therapies. The inherent tumor tropic and immune-modulatory properties of MSCs can be used to target cancer cells. This review aims to focus on the anticancer properties of MSCs and their effect on different signaling pathways. Later on, we discuss the advantages of engineered MSCs over non-engineered MSCsin cancer therapy. � 2023 John Wiley & Sons Australia, Ltd.en_US
dc.identifier.doi10.1111/ajco.13969
dc.identifier.issn17437555
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/4254
dc.identifier.urlhttps://onlinelibrary.wiley.com/doi/10.1111/ajco.13969
dc.language.isoen_USen_US
dc.publisherJohn Wiley and Sons Incen_US
dc.subjectantitumor activityen_US
dc.subjectexosomesen_US
dc.subjectmesenchymal stem cellsen_US
dc.subjectnanoparticlesen_US
dc.subjectsignaling pathwaysen_US
dc.titleMesenchymal stem cells- an excellent therapeutic agent for canceren_US
dc.title.journalAsia-Pacific Journal of Clinical Oncologyen_US
dc.typeReviewen_US
dc.type.accesstypeOpen Accessen_US

Files